Top cited articles

Acceptance rate

37%

Time to first decision

21 days*

Time from acceptance to publication

18 days*

Impact Factor

5.117

Citescore

6.1

Citescore rank

14/56

Storm, typhoon, cyclone or hurricane in patients with COVID-19? Beware of the same storm that has a different origin
Alunno, Alessia; Carubbi, Francesco; Rodriguez-Carrio, Javier
10.1136/rmdopen-2020-001295

Reactive arthritis after COVID-19 infection
Ono, Keisuke; Kishimoto, Mitsumasa; Shimasaki, Teppei. et al
10.1136/rmdopen-2020-001350

Management of thrombotic and obstetric antiphospholipid syndrome: a systematic literature review informing the EULAR recommendations for the management of antiphospholipid syndrome in adults
Tektonidou, Maria G.; Andreoli, Laura; Limper, Marteen. et al
10.1136/rmdopen-2019-000924

Long-term safety of certolizumab pegol in rheumatoid arthritis, axial spondyloarthritis, psoriatic arthritis, psoriasis and Crohn’s disease: a pooled analysis of 11 317 patients across clinical trials
Curtis, Jeffrey R.; Mariette, Xavier; Gaujoux-Viala, Cecile. et al
10.1136/rmdopen-2019-000942

Efficacy, immunogenicity and safety of vaccination in adult patients with autoimmune inflammatory rheumatic diseases: a systematic literature review for the 2019 update of EULAR recommendations
Rondaan, Christien; Furer, Victoria; Heijstek, Marloes W. et al
10.1136/rmdopen-2019-001035

Incidence and prevalence of vaccine preventable infections in adult patients with autoimmune inflammatory rheumatic diseases (AIIRD): a systemic literature review informing the 2019 update of the EULAR recommendations for vaccination in adult patients with AIIRD
Furer, Victoria; Rondaan, Christien; Heijstek, Marloes. et al
10.1136/rmdopen-2019-001041

Era of biosimilars in rheumatology: reshaping the healthcare environment
Smolen, Josef S.; Goncalves, Joao; Quinn, Mark. et al
10.1136/rmdopen-2019-000900

Serious infection risk in rheumatoid arthritis compared with non-inflammatory rheumatic and musculoskeletal diseases: a US national cohort study
Mehta, Bella; Pedro, Sofia; Ozen, Gulsen. et al
10.1136/rmdopen-2019-000935

EULAR points to consider for the development, evaluation and implementation of mobile health applications aiding self-management in people living with rheumatic and musculoskeletal diseases
Najm, Aurelie; Nikiphorou, Elena; Kostine, Marie. et al
10.1136/rmdopen-2019-001014

Low rates of radiographic progression of structural joint damage over 2 years of baricitinib treatment in patients with rheumatoid arthritis
van Der Heijde, Desiree; Schiff, Michael; Tanaka, Yoshiya. et al
10.1136/rmdopen-2019-000898

Glucocorticoids in rheumatoid arthritis: current status and future studies
Hua, Charlotte; Buttgereit, Frank; Combe, Bernard
10.1136/rmdopen-2017-000536

Efficacy and safety of biologics in psoriatic arthritis: a systematic literature review and network meta-analysis
Ruyssen-Witrand, Adeline; Perry, Richard; Watkins, Clare. et al
10.1136/rmdopen-2019-001117

National registry for patients with inflammatory rheumatic diseases (IRD) infected with SARS-CoV-2 in Germany (ReCoVery): a valuable mean to gain rapid and reliable knowledge of the clinical course of SARS-CoV-2 infections in patients with IRD
Hasseli, Rebecca; Mueller-Ladner, Ulf; Schmeiser, Tim. et al
10.1136/rmdopen-2020-001332

Long-term safety of tofacitinib up to 9.5 years: a comprehensive integrated analysis of the rheumatoid arthritis clinical development programme
Cohen, Stanley B.; Tanaka, Yoshiya; Mariette, Xavier; Curtis, Jeffrey R.; Lee, Eun Bong; Nash, Peter; Winthrop, Kevin L.; Charles-Schoeman, Christina; Wang, Lisy. et al
10.1136/rmdopen-2020-001395

Efficacy and safety of rituximab in the treatment of eosinophilic granulomatosis with polyangiitis
Teixeira, Vitor; Mohammad, Aladdin J.; Jones, Rachel B. et al
10.1136/rmdopen-2019-000905

Systematic literature review informing the 2018 update of the EULAR recommendation for the management of large vessel vasculitis: focus on giant cell arteritis
Monti, Sara; Agueda, Ana F.; Luqmani, Raashid Ahmed. et al
10.1136/rmdopen-2019-001003

Is it Kawasaki shock syndrome, Kawasaki-like disease or pediatric inflammatory multisystem disease? The importance of semantic in the era of COVID-19 pandemic
Kone-Paut, Isabelle; Cimaz, Rolando
10.1136/rmdopen-2020-001333

Rheumatology practice amidst the COVID-19 pandemic: a pragmatic view
Romao, Vasco C.; Cordeiro, Ines; Macieira, Carla. et al
10.1136/rmdopen-2020-001314

Dual neutralisation of IL-17F and IL-17A with bimekizumab blocks inflammation-driven osteogenic differentiation of human periosteal cells
Shah, Mittal; Maroof, Asher; Gikas, Panos. et al
10.1136/rmdopen-2020-001306

Impact of fatigue on health-related quality of life and illness perception in a monocentric cohort of patients with systemic lupus erythematosus
Elefante, Elena; Tani, Chiara; Stagnaro, Chiara. et al
10.1136/rmdopen-2019-001133